Chemours (CC) Operating Expenses (2016 - 2025)
Historic Operating Expenses for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $139.0 million.
- Chemours' Operating Expenses fell 4794.01% to $139.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 1518.26%. This contributed to the annual value of $823.0 million for FY2024, which is 4680.03% down from last year.
- Per Chemours' latest filing, its Operating Expenses stood at $139.0 million for Q3 2025, which was down 4794.01% from $483.0 million recorded in Q2 2025.
- Over the past 5 years, Chemours' Operating Expenses peaked at $806.0 million during Q2 2023, and registered a low of $139.0 million during Q3 2025.
- In the last 5 years, Chemours' Operating Expenses had a median value of $190.0 million in 2021 and averaged $248.7 million.
- In the last 5 years, Chemours' Operating Expenses soared by 18785.71% in 2023 and then crashed by 7729.53% in 2024.
- Chemours' Operating Expenses (Quarter) stood at $190.0 million in 2021, then increased by 11.05% to $211.0 million in 2022, then rose by 21.8% to $257.0 million in 2023, then fell by 20.62% to $204.0 million in 2024, then tumbled by 31.86% to $139.0 million in 2025.
- Its Operating Expenses was $139.0 million in Q3 2025, compared to $483.0 million in Q2 2025 and $183.0 million in Q1 2025.